Molecular Imaging of the Tumor Microenvironment Reveals the Relationship between Tumor Oxygenation, Glucose Uptake, and Glycolysis in Pancreatic Ductal Adenocarcinoma
暂无分享,去创建一个
James B. Mitchell | P. Choyke | J. Brender | E. Jagoda | M. Krishna | S. Kishimoto | Keita Saito | Tomohiro Seki | Nobu Oshima | Kazu Yamamoto | N. Devasahayam | S. Adler | R. Choudhuri
[1] Xiaofei Li,et al. Lactate dehydrogenase A: A key player in carcinogenesis and potential target in cancer therapy , 2018, Cancer medicine.
[2] Majbrit M E Larsen,et al. Combined hyperpolarized 13C-pyruvate MRS and 18F-FDG PET (hyperPET) estimates of glycolysis in canine cancer patients. , 2018, European journal of radiology.
[3] Chi V Dang,et al. Exploiting Metabolic Vulnerabilities of Cancer with Precision and Accuracy. , 2017, Trends in cell biology.
[4] R. Arora,et al. Overexpression of hypoxia-inducible factor and metabolic pathways: possible targets of cancer , 2017, Cell & Bioscience.
[5] Timothy W. Secomb,et al. Transport of drugs from blood vessels to tumour tissue , 2017, Nature Reviews Cancer.
[6] D. Urban,et al. Discovery and Optimization of Potent, Cell-Active Pyrazole-Based Inhibitors of Lactate Dehydrogenase (LDH). , 2017, Journal of medicinal chemistry.
[7] Tumor LDH-A expression and serum LDH status are two metabolic predictors for triple negative breast cancer brain metastasis , 2017, Scientific Reports.
[8] Gerald C. Chu,et al. Compensatory metabolic networks in pancreatic cancers upon perturbation of glutamine metabolism , 2017, Nature Communications.
[9] Matthew G. Vander Heiden,et al. Understanding the Intersections between Metabolism and Cancer Biology , 2017, Cell.
[10] R. Gillies,et al. PET and MRI: Is the Whole Greater than the Sum of Its Parts? , 2016, Cancer research.
[11] Shingo Matsumoto,et al. Pyruvate sensitizes pancreatic tumors to hypoxia-activated prodrug TH-302 , 2015, Cancer & metabolism.
[12] E. Taylor,et al. Regulation of pyruvate metabolism and human disease , 2013, Cellular and Molecular Life Sciences.
[13] Martin O. Leach,et al. Model Free Approach to Kinetic Analysis of Real-Time Hyperpolarized 13C Magnetic Resonance Spectroscopy Data , 2013, PloS one.
[14] A. Haase,et al. Multimodal Assessment of In Vivo Metabolism with Hyperpolarized [1-13C]MR Spectroscopy and 18F-FDG PET Imaging in Hepatocellular Carcinoma Tumor–Bearing Rats , 2013, The Journal of Nuclear Medicine.
[15] Gerald C. Chu,et al. Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism , 2012, Cell.
[16] P. Ward,et al. Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. , 2012, Cancer cell.
[17] J. Shea,et al. Phenotype and Genotype of Pancreatic Cancer Cell Lines , 2010, Pancreas.
[18] C. Van de Wiele,et al. FDG uptake, a surrogate of tumour hypoxia? , 2008, European Journal of Nuclear Medicine and Molecular Imaging.
[19] R. Deberardinis,et al. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. , 2008, Cell metabolism.
[20] Jens Overgaard,et al. Hypoxic radiosensitization: adored and ignored. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] A. Rowan. Guide for the Care and Use of Laboratory Animals , 1979 .